Evidence map›Paper›PMID 38057907›Full record

ArticleFluids and barriers of the CNS2023

Preventive effect of intermittent cerebrospinal fluid drainage for secondary chronic hydrocephalus after aneurysmal subarachnoid hemorrhage.

Tomoyasu Yamanaka, Yusuke Nishikawa, Takashi Iwata, Teishiki Shibata, Mitsuru Uchida, Yuki Hayashi, Hiroyuki Katano, Motoki Tanikawa, Shigeki Yamada, Mitsuhito Mase

Abstract read
In one paragraph

Article in Fluids and barriers of the CNS, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Tomoyasu YamanakaDepartment of Neurosurgery, Graduate School of Medical Science, Nagoya City University, Kawasumi 1, Mizuho-cho, Mizuho-ku, Nagoya City, Aichi, 467-8601, Japan.
Yusuke NishikawaDepartment of Neurosurgery, Graduate School of Medical Science, Nagoya City University, Kawasumi 1, Mizuho-cho, Mizuho-ku, Nagoya City, Aichi, 467-8601, Japan.
Takashi IwataDepartment of Neurosurgery, Nagoya City East Medical Center, Aichi, Japan.
Teishiki ShibataDepartment of Neurosurgery, Graduate School of Medical Science, Nagoya City University, Kawasumi 1, Mizuho-cho, Mizuho-ku, Nagoya City, Aichi, 467-8601, Japan.
Mitsuru UchidaDepartment of Neurosurgery, Graduate School of Medical Science, Nagoya City University, Kawasumi 1, Mizuho-cho, Mizuho-ku, Nagoya City, Aichi, 467-8601, Japan.
Yuki HayashiDepartment of Neurosurgery, Graduate School of Medical Science, Nagoya City University, Kawasumi 1, Mizuho-cho, Mizuho-ku, Nagoya City, Aichi, 467-8601, Japan.
Hiroyuki KatanoDepartment of Neurosurgery, Graduate School of Medical Science, Nagoya City University, Kawasumi 1, Mizuho-cho, Mizuho-ku, Nagoya City, Aichi, 467-8601, Japan.
Motoki TanikawaDepartment of Neurosurgery, Graduate School of Medical Science, Nagoya City University, Kawasumi 1, Mizuho-cho, Mizuho-ku, Nagoya City, Aichi, 467-8601, Japan.
Shigeki YamadaDepartment of Neurosurgery, Graduate School of Medical Science, Nagoya City University, Kawasumi 1, Mizuho-cho, Mizuho-ku, Nagoya City, Aichi, 467-8601, Japan. shigekiyamada393@gmail.com.
Mitsuhito MaseDepartment of Neurosurgery, Graduate School of Medical Science, Nagoya City University, Kawasumi 1, Mizuho-cho, Mizuho-ku, Nagoya City, Aichi, 467-8601, Japan. mitmase@med.nagoya-cu.ac.jp.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe efficacy of intermittent cerebrospinal fluid (CSF) drainage compared with that of continuous CSF drainage in patients with subarachnoid hemorrhage (SAH) remains undetermined to date. Therefore, we investigated whether intermittent CSF drainage is effective in reducing secondary chronic hydrocephalus (sCH) after aneurysmal SAH.

methodsOverall, 204 patients (69 men and 135 women) treated for aneurysmal SAH between 2007 and 2022 were included in this study. Following SAH onset, 136 patients were managed with continuous CSF drainage, whereas 68 were managed with intermittent CSF drainage. Logistic regression analyses were used to calculate the age-adjusted and multivariate odds ratios for the development of sCH. The Cox proportional hazards regression model were used to compare the effects of intermittent and continuous CSF drainage on sCH development.

resultsOverall, 96 patients developed sCH among the 204 patients with SAH. In total, 74 (54.4%) of the 136 patients managed with continuous CSF drainage developed sCH, whereas 22 (32.4%) of the 68 patients managed with intermittent CSF drainage developed sCH. This demonstrated that the rate of sCH development was significantly lower among patients managed with intermittent CSF drainage. Compared with continuous CSF drainage, intermittent CSF drainage exhibited a multivariate odds ratio (95% confidential interval) of 0.25 (0.11-0.57) for sCH development. Intermittent CSF drainage was more effective (0.20, 0.04-0.95) in patients with severe-grade SAH than in those with mild-grade SAH (0.33, 0.12-0.95). Intermittent CSF drainage was ineffective in patients with acute hydrocephalus (8.37, 0.56-125.2), but it was effective in patients without acute hydrocephalus (0.11, 0.04-0.31).

conclusionsCompared with continuous CSF drainage, intermittent drainage is more effective in reducing sCH after aneurysmal SAH. Although intermittent drainage was ineffective in cases of co-occurrence of acute hydrocephalus, it was effective in reducing sCH development regardless of the severity of initial symptoms at SAH onset.

Indexed as

HydrocephalusSubarachnoid HemorrhageCerebrospinal Fluid LeakDrainageFemaleHumansMaleAcute hydrocephalusChronic hydrocephalusCoil embolizationCSF drainageSubarachnoid Hemorrhage

Identifiers

PMID38057907
PMCPMC10702125

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.